Concepedia

Ke Geng

KG

14

Publications

736

Citations

13

H-Index

1998

Active since

Affiliations

Rutgers, The State University of New Jersey(Current)

New York University

Rutgers New Jersey Medical School

Office of Science

NYU Langone Health

Ke Geng is an author at Rutgers, The State University of New Jersey specializing in tumor biology, tumor immunology, and tumor immunity.

Top concepts

MedicineImmunologyCell BiologyBreast CancerImmunotherapyTumor BiologyCancer BiologyCell MigrationCell SignalingImmune Evasion

Publications per year

1998–2024

14

Publications

14

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

Canan Kasikara, Viralkumar Davra, David Calianese et al. · Cancer Research · 2019 · 130 citations

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression

Canan Kasikara, Sushil Kumar, Stanley Kimani et al. · Molecular Cancer Research · 2017 · 122 citations · Full text

Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Viralkumar Davra, Sushil Kumar, Ke Geng et al. · Cancer Research · 2020 · 90 citations · Full text

KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition

Yuanwang Pan, Han Han, Hai Hu et al. · Cancer Cell · 2022 · 81 citations · Full text

Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6

Ke Geng, Sushil Kumar, Stanley Kimani et al. · Frontiers in Immunology · 2017 · 77 citations · Full text

Rows per page

1–5 of 14